These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8212269)

  • 41. Role of microchimerism on long-term graft survival after donor-specific transfusion in a rat heart transplantation model.
    Ito H; Hamano K; Gohra H; Katoh T; Fujimura Y; Zempo N; Esato K
    Transplant Proc; 1998 Nov; 30(7):3862-4. PubMed ID: 9838690
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacologic alteration of the donor specific transfusion effect.
    Waymack JP; Alexander JW
    Transplant Proc; 1988 Feb; 20(1):124-7. PubMed ID: 3278454
    [No Abstract]   [Full Text] [Related]  

  • 43. Modulation of alloimmunity with class I MHC peptides: mechanisms of action.
    Mhoyan A; Wu GD; Que X; Cramer DV; Shirwan H
    Transplant Proc; 1999; 31(1-2):1189-91. PubMed ID: 10083530
    [No Abstract]   [Full Text] [Related]  

  • 44. Local inhibition of major histocompatibility complex class II induction within the graft: an effective way to induce immunosuppression.
    Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):246-7. PubMed ID: 3152698
    [No Abstract]   [Full Text] [Related]  

  • 45. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
    Motoyama K; Lehmann M; Flye MW
    Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanisms of immunosuppression by serum from liver grafted rats: demonstration of suppressor cell activity in vivo and in vitro.
    Kamada N; Yamaguchi A; Yoshimura S; Sumimoto R; Teramoto K; Baquerizo A
    Transplant Proc; 1990 Aug; 22(4):1973-4. PubMed ID: 2143867
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation.
    Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M
    Transplant Proc; 1999 Nov; 31(7):2796-8. PubMed ID: 10578296
    [No Abstract]   [Full Text] [Related]  

  • 48. Blood transfusion plus allograft--but not blood transfusion alone--induce IL 2-producing suppressor cells in Lew-1A recipients of LEW-1W heart allograft.
    Chevalier S; Lacroix H; Moreau JF; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):544-6. PubMed ID: 2978922
    [No Abstract]   [Full Text] [Related]  

  • 49. Manipulations of arachidonic acid metabolism using a 5-lipoxygenase inhibitor in transfusion-induced immunosuppression.
    Heyd TJ; Perez RV; Trocki O; Alexander JW
    Transplant Proc; 1988 Dec; 20(6):1186-9. PubMed ID: 3144072
    [No Abstract]   [Full Text] [Related]  

  • 50. Contributions of the rat to the immunobiology of tissue transplantation.
    Silvers WK; Billingham RE
    Transplant Proc; 1970 Mar; 2(1):152-61. PubMed ID: 4398945
    [No Abstract]   [Full Text] [Related]  

  • 51. Antigen-induced immunosuppression for organ grafting.
    Calne RY
    Transplant Proc; 1971 Mar; 3(1):21-6. PubMed ID: 4106310
    [No Abstract]   [Full Text] [Related]  

  • 52. A detailed analysis of the potential of water soluble classical class I MHC molecules for donor-specific immunosuppression in transplantation.
    Priestley CA; Dalchau R; Sawyer GJ; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1949-51. PubMed ID: 2389492
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunomodulation of donor-specific transfusions.
    Waymack JP; Munda R; Johnson C; Alexander JW
    Transplantation; 1987 May; 43(5):761-4. PubMed ID: 3554670
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of major histocompatibility disparity on mycophenolate mofetil immunosuppression in rat pancreas transplantation.
    Schulak JA; Krishnamurthi V; Masih R; Robinson A
    Transplant Proc; 1995 Dec; 27(6):3010-1. PubMed ID: 8539816
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma MHC class I expression in cardiac graft patients: donor-specific soluble antigen in a presensitised graft patient.
    Zavazava N; Kraatz E; Gassel AM; Müller-Ruchholtz W
    Transplant Proc; 1991 Aug; 23(4):2258-60. PubMed ID: 1871865
    [No Abstract]   [Full Text] [Related]  

  • 56. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences.
    Qian S; Sun H; Demetris AJ; Fu F; Starzl TE; Fung JJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):362-3. PubMed ID: 8438336
    [No Abstract]   [Full Text] [Related]  

  • 57. Humoral mechanism of split tolerance to lymphocyte and heart allografts after donor-specific transfusion.
    Jasklowska-Englisz M; Olszewski WL; Maksymowicz M; Poreda E; Ziolkowska A
    Transplant Proc; 1997 Jun; 29(4):2185-6. PubMed ID: 9193581
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanisms of immunosuppression by serum from liver grafted rats: evidence for functional clonal deletion in vivo.
    Kamada N; Yamaguchi A; Yoshimura S; Sumimoto R; Teramoto K; Baquerizo A
    Transplant Proc; 1990 Aug; 22(4):1971-2. PubMed ID: 2389501
    [No Abstract]   [Full Text] [Related]  

  • 59. [Current status of human renal allograft and experimental prolongation of renal graft survival].
    Hirano T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):389-92. PubMed ID: 6386637
    [No Abstract]   [Full Text] [Related]  

  • 60. Specific inhibition of organ allograft rejection by donor blood.
    Marquet RL; Heystek GA; Tinbergen WJ
    Transplant Proc; 1971 Mar; 3(1):708-10. PubMed ID: 4937963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.